Osteoporosis International

Aims & Scope

An international multi-disciplinary journal which is a joint initiative between the International Osteoporosis Foundation and the National Osteoporosis Foundation of the USA, Osteoporosis International provides a forum for the communication and exchange of current ideas concerning the diagnosis, prevention, treatment and management of osteoporosis and other metabolic bone diseases.

It publishes: original papers - reporting progress and results in all areas of osteoporosis and its related fields; review articles - reflecting the present state of knowledge in special areas of summarizing limited themes in which discussion has led to clearly defined conclusions; educational articles - giving information on the progress of a topic of particular interest; case reports - of uncommon or interesting presentations of the condition.

While focusing on clinical research, the Journal will also accept submissions on more basic aspects of research, where they are considered by the editors to be relevant to the human disease spectrum.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	5.4
2024	4.20

SJR (SCImago Journal Rank)

Year	Value
2024	1.466

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	201

Journal Rank

Year	Value
2024	2497

Journal Citation Indicator

Year	Value
2024	2880

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• An estimate of the worldwide prevalence and disability associated with osteoporotic fractures

  Citation: 3600

  Authors: O., J. A.

• Clinician’s Guide to Prevention and Treatment of Osteoporosis

  Citation: 2535

  Authors: F., S. J., M. S., E. M., B., S., R.

• Hip fractures in the elderly: A world-wide projection

  Citation: 2333

  Authors: C., G., L. J.

• FRAXâ„¢ and the assessment of fracture probability in men and women from the UK

  Citation: 1952

  Authors: J. A., O., A., H., E.

• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report

  Citation: 1877

  Authors: J. A., J. A.

• World-wide Projections for Hip Fracture

  Citation: 1713

  Authors: B., O., J.A.

• Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis

  Citation: 1495

  Authors: P.

• Estimates of optimal vitamin D status

  Citation: 1373

  Authors: Bess, Robert P., Michael F., Paul, Pierre J., Reinhold

• European guidance for the diagnosis and management of osteoporosis in postmenopausal women

  Citation: 1362

  Authors: J.A., C., R., J.-Y.

• Body mass index as a predictor of fracture risk: A meta-analysis

  Citation: 1208

  Authors: C., J. A., A., H., O., P., J. A., H., S., P., E. V., D., L. J., P. J., H. A. P., J., A., A.

---